Northern Trust’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-102,282
| Closed | -$2.76M | – | 4659 |
|
2022
Q4 | $2.76M | Buy |
102,282
+3,549
| +4% | +$95.7K | ﹤0.01% | 2827 |
|
2022
Q3 | $1.77M | Buy |
98,733
+128
| +0.1% | +$2.3K | ﹤0.01% | 3078 |
|
2022
Q2 | $1.23M | Buy |
98,605
+7,027
| +8% | +$87.3K | ﹤0.01% | 3286 |
|
2022
Q1 | $1.22M | Sell |
91,578
-1,646
| -2% | -$21.9K | ﹤0.01% | 3336 |
|
2021
Q4 | $1.45M | Sell |
93,224
-231
| -0.2% | -$3.6K | ﹤0.01% | 3390 |
|
2021
Q3 | $2.1M | Buy |
93,455
+2,929
| +3% | +$65.7K | ﹤0.01% | 3265 |
|
2021
Q2 | $2.06M | Buy |
90,526
+892
| +1% | +$20.3K | ﹤0.01% | 3342 |
|
2021
Q1 | $1.85M | Buy |
89,634
+79,471
| +782% | +$1.64M | ﹤0.01% | 3286 |
|
2020
Q4 | $281K | Sell |
10,163
-7
| -0.1% | -$194 | ﹤0.01% | 3884 |
|
2020
Q3 | $143K | Buy |
10,170
+12
| +0.1% | +$169 | ﹤0.01% | 3882 |
|
2020
Q2 | $209K | Sell |
10,158
-126
| -1% | -$2.59K | ﹤0.01% | 3750 |
|
2020
Q1 | $78K | Buy |
10,284
+173
| +2% | +$1.31K | ﹤0.01% | 3870 |
|
2019
Q4 | $157K | Sell |
10,111
-1,403
| -12% | -$21.8K | ﹤0.01% | 3850 |
|
2019
Q3 | $59K | Sell |
11,514
-1
| -0% | -$5 | ﹤0.01% | 4032 |
|
2019
Q2 | $105K | Buy |
+11,515
| New | +$105K | ﹤0.01% | 3966 |
|
2018
Q4 | – | Sell |
-29,847
| Closed | -$792K | – | 4324 |
|
2018
Q3 | $792K | Buy |
+29,847
| New | +$792K | ﹤0.01% | 3531 |
|
2017
Q2 | – | Sell |
-83,593
| Closed | -$981K | – | 4312 |
|
2017
Q1 | $981K | Buy |
83,593
+2,948
| +4% | +$34.6K | ﹤0.01% | 3356 |
|
2016
Q4 | $1M | Buy |
+80,645
| New | +$1M | ﹤0.01% | 3349 |
|